Bal Pharma Limited — Results, 27-07-2026: Reply to Clarification- Financial results
27-07-2026 | 04:10 pm
27-07-2026 | 04:10 pm
Bal Pharma clarified XBRL submission discrepancies for PAT, EPS, and Cash Flow were technical errors, not financial revisions. Original PDF results are final and correct. XBRL has been refiled to align, ensuring consistency without impacting previously approved figures.
No comments yet. Be the first to comment!
